Drugs / R-Pdf/Gbb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00812513 | Jul 2011 → Apr 2012 | — | American Scitech International | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-Pdf/Gbb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00812513 ↗ |
| Modality | Protein / enzyme biologic | “The R-Pdf/Gbb is recombinant human platelet-derived growth factor.” NCT00812513 ↗ |
| Route | Topical | “rhPDGF 0.01% gel is applied to the wound” NCT00812513 ↗ |